Valuation: Boryung Corporation

Market Cap 701B 472M 412M 380M 351M 661M 45.41B 675M 4.55B 1.79B 22.24B 1.77B 1.73B 76.56B P/E 2026 *
10.8x
P/E 2027 * 10.4x
Enterprise Value 701B 472M 412M 380M 351M 661M 45.41B 675M 4.55B 1.79B 22.24B 1.77B 1.73B 76.56B EV / Sales 2026 *
0.66x
EV / Sales 2027 * 0.65x
Free-Float
32.71%
Yield 2026 *
1.93%
Yield 2027 * 1.93%
1 day+0.97%
1 week+2.85%
Current month-1.31%
1 month-12.08%
3 months-18.63%
6 months-4.60%
Current year-7.88%
1 week 7,910
Extreme 7910
8,660
1 month 7,910
Extreme 7910
9,580
Current year 7,910
Extreme 7910
10,800
1 year 7,910
Extreme 7910
10,800
3 years 7,440
Extreme 7440
13,750
5 years 7,440
Extreme 7440
19,550
10 years 5,743.71
Extreme 5743.7069
25,083.33
Manager TitleAgeSince
Chief Executive Officer 41 24/03/2022
Director of Finance/CFO 51 -
Chief Tech/Sci/R&D Officer 55 -
Director TitleAgeSince
Director/Board Member 39 24/03/2022
Director/Board Member 94 -
Chairman 68 18/05/2014
Date Insider Type Main position Quantity % Market Cap.
12/06/25 Buy 117,572 0.1355%
12/06/25 Buy

Director

400,000 0.4609%
22/05/25 Buy

Responsable ventes & marketing

1,502 0.0017%
Change 5-day change 1-year change 3-year change Capi.($)
+0.97%+2.85%-2.01%+3.11% 473M
-0.90%-0.31%+13.62%+80.12% 48.56B
-0.23%-0.63%+67.00%+115.81% 35.65B
-0.76%-1.57%-3.87%+37.62% 11.98B
-0.88%-1.32%+18.04%+92.11% 11.95B
+1.12%+1.90%+34.67%+129.06% 9.29B
-0.75%-0.91%+18.26%+37.23% 6.95B
+3.37%-0.96%+46.11%-4.38% 6.79B
-2.25%-1.40%+1.39%+218.40% 6.7B
-9.93%+5.82%-22.89%+16.29% 6.81B
Average -1.02%+0.31%+17.03%+72.54% 14.51B
Weighted average by Cap. -0.87%+0.32%+26.41%+86.63%

Financials

2026 *2027 *
Net sales 1,058B 711M 622M 574M 529M 997M 68.5B 1.02B 6.86B 2.7B 33.55B 2.67B 2.61B 115B 1,084B 729M 637M 588M 542M 1.02B 70.22B 1.04B 7.03B 2.76B 34.39B 2.74B 2.68B 118B
Net income 66.2B 44.52M 38.91M 35.9M 33.09M 62.37M 4.29B 63.76M 429M 169M 2.1B 167M 164M 7.23B 68.2B 45.86M 40.08M 36.99M 34.09M 64.26M 4.42B 65.68M 442M 174M 2.16B 172M 168M 7.45B
Net Debt - -
Logo Boryung Corporation
Boryung Corp, formerly Boryung Pharm Co Ltd, is a Korea-based company principally engaged in the manufacture and sale of pharmaceutical products. The Company mainly manufactures and distributes pharmaceutical products including antihypertensive drugs, gastrointestinal disorder drugs, antibiotics, gastric ulcer drugs, oral antibiotics, anticancer drugs and antihyperlipidemic drugs, among others. The Company distributes its products in domestic and overseas markets.
Employees
1,533
Date Price Change Volume
16/07/26 ₩8,300.00 +0.97% 82,987
15/07/26 ₩8,220.00 +2.88% 95,331
14/07/26 ₩7,990.00 -2.44% 142,489
13/07/26 ₩8,190.00 -3.31% 113,305
10/07/26 ₩8,470.00 +4.96% 114,276
Trader
-
Investor
Global
-
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
8,300.00KRW
Average target price
14,000.00KRW
Spread / Average Target
+68.67%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A003850 Stock